GSM城市站国家站国际

阿普拉霉素葡聚糖纳米颗粒对11株鲍曼不动杆菌体外活性与游离药物无显著差异

2026-11-16 · 科技 · GSM News
阿普拉霉素葡聚糖纳米颗粒对11株鲍曼不动杆菌体外活性与游离药物无显著差异

西班牙 Biogipuzkoa 健康研究所、CIDETEC 和巴斯克大学研究人员11月15日在 Scientific Reports 发表论文:把阿普拉霉素制成葡聚糖基单链聚合物纳米颗粒后,对11株鲍曼不动杆菌临床分离株的体外抗菌活性与游离药物相比,总体上没有显著差异。

研究制备了一系列理化性质不同的纳米颗粒制剂,包括低、中、高三种取代度,以及中取代度下低、高两种交联度,并用最低抑菌浓度、最低杀菌浓度和时间杀菌动力学试验,把制剂与游离药物在11株鲍曼不动杆菌临床分离株上作比较。

结果显示,游离阿普拉霉素与制剂阿普拉霉素的抗菌活性总体上没有统计学显著差异。不过,中取代度制剂和高交联制剂呈现出活性略高的趋势。

研究人员表示,抗菌药物耐药在全球出现,正推动治疗细菌感染新策略的开发,葡聚糖基单链聚合物纳米颗粒被开发为治疗肺部感染的抗生素递送系统。本研究为体外试验结果。

Apramycin in Dextran Nanoparticles Shows No Significant Difference From Free Drug Against 11 Acinetobacter baumannii Isolates In Vitro

Researchers at the Biogipuzkoa Health Research Institute, CIDETEC and the University of the Basque Country in Spain published a paper in Scientific Reports on 15 November: apramycin formulated with dextran-based single-chain polymeric nanoparticles showed, overall, no significant difference from the free drug in in vitro antimicrobial activity against eleven Acinetobacter baumannii clinical isolates.

The team formulated a series of nanoparticles with different physicochemical properties, namely three degrees of substitution, low, medium or high, and two degrees of crosslinking at a medium degree of substitution, low or high. Their in vitro activity against eleven Acinetobacter baumannii clinical isolates was assessed compared with the free drug, using minimum inhibitory concentration, minimum bactericidal concentration and time-kill kinetic assays.

Overall, no statistically significant differences were observed between the antimicrobial activity of free and formulated apramycin. Nevertheless, a slight trend towards higher activity was observed in the cases of the medium-substitution and high-crosslinking formulations.

The authors said the global emergence of antimicrobial resistance is driving the development of novel strategies for treating bacterial infections, and that dextran-based single-chain polymeric nanoparticles have been developed as antibiotic delivery systems for the treatment of pulmonary infections. The study reports in vitro results.

来源:Scientific Reports

发布:GSM·美国(发布链接)

图片来源:图中是扫描电子显微镜下的鲍曼不动杆菌,本研究测试的细菌。来源:Wikimedia Commons,Vader1941,CC BY-SA

GSM Global · 本篇英文版 English edition of this story

本频道最新更多 ›

← 返回科技 全部新闻 关于我们

GSM首页白宫联邦加州南加各州社会军事司法选举世界中国城市站国家站移民宣传专题视频直播放映厅电子书电子报科技金融教育医疗影视音乐体育文旅时尚演出活动娱乐游戏生活美食户外交通汽车地产保险儿童长者留学生宠物信仰非盈利机构